Innovent, MicuRx seeking Hong Kong IPOs

Immuno-oncology company Innovent Biologics Inc. (Suzhou, China) and anti-infectives company MicuRx Pharmaceuticals Inc. (Hayward, Calif.) each filed on June 28 to list on the Hong Kong stock exchange.

Innovent's filing is underwritten by Morgan Stanley, Goldman Sachs, J.P. Morgan and CMS. Jefferies is the sole underwriter for MicuRx...